New Drug Approvals: July 2004

Date of Approval: July 21, 2004

Company: Romark Laboratories

Treatment for Traveler's Diarrhea

Alinia is an antiprotozoal agent indicated for the treatment of diarrhea caused by Giardia lamblia in patients 12 years of age and older.

Company: Merck/Schering-Plough Pharmaceuticals

Treatment for Cholesterol Reduction

Company: MedImmune, Inc.

Treatment for Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease

Date of Approval: July 27, 2004

Company: PhotoCure ASA

Treatment for Keratosis

Metvixia is a non-invasive treatment which combines the local application of cream, selectively absorbed into abnormal cells, and illumination with a proprietary red light source (CureLight/Aktilite) to activate the drug for the photodynamic treatment of sun-induced pre-cancerous skin lesions (actinic keratosis).

Date of Approval: July 29, 2004

Company: Forest Laboratories, Inc. and Merck

Treatment for Alcohol Dependence

Campral, the first new drug approved for alcohol abuse in a decade, is used for treating alcohol dependent individuals seeking to continue to remain alcohol-free after they have stopped drinking.